Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase I Study Of Intraperitoneal Egen-001 Administered In Combination With Pegylated Liposomal Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Cancer.
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.